Cancer Center Support Grant View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1977-2018

FUNDING AMOUNT

221726884 USD

ABSTRACT

SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER Memorial Sloan-Kettering Cancer Center (MSKCC) is a free-standing NCI-designated Comprehensive Cancer Research Center dedicated to research and training, with the mission of changing and setting the standards of treatment, prevention and control of cancer through inpatient and outpatient care. MSKCC's research programs are grouped into three categories: Basic Research (Regulation of Cell Behavior, Developmental and Stem Cell Biology, Genomic Integrity, and Molecular Structure); Bridge Research (Cancer Biology and Experimental Pathology, Experimental Therapeutics, Immunology and Transplantation, and Imaging and Radiation Sciences); and Patient-Oriented Research (Clinical Research and Survivorship, Outcomes and Risk). The programs are designed to optimize the use of a large patient population and an extensive, multi-disciplinary staff of clinical and laboratory-based Investigators and to encourage the application of discoveries in the basic sciences in a way that advances the prevention, detection, diagnosis, and treatment of many forms of cancer. Scientific work in the 10 research programs depends on services provided by 34 core facilities. We are requesting funding from the Cancer Center Support Grant (CCSG) for 21 of these core facilities. During the next five years, MSKCC will continue to enlarge its clinical and research facilities and its research and training programs in key research areas. Support is requested to provide developmental funding for the laboratories of new Investigators recruited in research areas aligned with the Center's strategic vision, to support cross-disciplinary pilot projects in population science research, and to support the core facilities. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9406236

Related SciGraph Publications

  • 2019-12. Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas in NPJ BREAST CANCER
  • 2019-12. miR-193b regulates tumorigenesis in liposarcoma cells via PDGFR, TGFβ, and Wnt signaling in SCIENTIFIC REPORTS
  • 2019-12. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2019-12. Physical plasma-triggered ROS induces tumor cell death upon cleavage of HSP90 chaperone in SCIENTIFIC REPORTS
  • 2019-12. Acute and chronic demyelinated CNS lesions exhibit opposite elastic properties in SCIENTIFIC REPORTS
  • 2019-12. Imaging endogenous macrophage iron deposits reveals a metabolic biomarker of polarized tumor macrophage infiltration and response to CSF1R breast cancer immunotherapy in SCIENTIFIC REPORTS
  • 2019-12. Shared heritability and functional enrichment across six solid cancers in NATURE COMMUNICATIONS
  • 2019-12. Reversible histone glycation is associated with disease-related changes in chromatin architecture in NATURE COMMUNICATIONS
  • 2019-12. Persistent DNA-break potential near telomeres increases initiation of meiotic recombination on short chromosomes in NATURE COMMUNICATIONS
  • 2019-12. Structure of tRNA splicing enzyme Tpt1 illuminates the mechanism of RNA 2′-PO4 recognition and ADP-ribosylation in NATURE COMMUNICATIONS
  • 2019-12. Live imaging of leukocyte recruitment in a zebrafish model of chemical liver injury in SCIENTIFIC REPORTS
  • 2019-12. Genetic deletion of genes in the cerebellar rhombic lip lineage can stimulate compensation through adaptive reprogramming of ventricular zone-derived progenitors in NEURAL DEVELOPMENT
  • 2019-12. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma in NATURE COMMUNICATIONS
  • 2019-05. Volumetric 3D assessment of ablation zones after thermal ablation of colorectal liver metastases to improve prediction of local tumor progression in EUROPEAN RADIOLOGY
  • 2019-05. Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes in EUROPEAN JOURNAL OF HUMAN GENETICS
  • 2019-04-12. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases. in MODERN PATHOLOGY
  • 2019-04-08. Role of the Interval from Completion of Neoadjuvant Therapy to Surgery in Postoperative Morbidity in Patients with Locally Advanced Rectal Cancer. in ANNALS OF SURGICAL ONCOLOGY
  • 2019-04. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes in CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
  • 2019-04. Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy in ANNALS OF SURGICAL ONCOLOGY
  • 2019-04. Processes of Change for Colonoscopy: Limited Support for Use Among Navigated Latinos in JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES
  • 2019-04. Variation in the Thoroughness of Pathologic Assessment and Response Rates of Locally Advanced Rectal Cancers After Chemoradiation in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2019-04. Specification of positional identity in forebrain organoids in NATURE BIOTECHNOLOGY
  • 2019-04. Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings? in EUROPEAN RADIOLOGY
  • 2019-04. Effect of Neoadjuvant Systemic Chemotherapy With or Without Chemoradiation on Bowel Function in Rectal Cancer Patients Treated With Total Mesorectal Excision in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2019-04. Characterization of cell fate probabilities in single-cell data with Palantir in NATURE BIOTECHNOLOGY
  • 2019-04. Antibody–drug conjugate, GSK2857916, in relapsed/refractory multiple myeloma: an update on safety and efficacy from dose expansion phase I study in BLOOD CANCER JOURNAL
  • 2019-04. Smoking Among Chinese Livery Drivers in JOURNAL OF IMMIGRANT AND MINORITY HEALTH
  • 2019-04. Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2019-04. Prognostic value of baseline metabolic tumor volume measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in melanoma patients treated with ipilimumab therapy in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-04. Radiation Therapy After Breast-Conserving Surgery in Women 70 Years of Age and Older: How Wisely Do We Choose? in ANNALS OF SURGICAL ONCOLOGY
  • 2019-03-28. Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices in MODERN PATHOLOGY
  • 2019-03-25. FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels in NATURE NANOTECHNOLOGY
  • 2019-03-16. Targeted radioimmunotherapy for embryonal tumor with multilayered rosettes in JOURNAL OF NEURO-ONCOLOGY
  • 2019-03-13. Efficacy of MEK inhibition in patients with histiocytic neoplasms in NATURE
  • 2019-03. Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment in CURRENT BREAST CANCER REPORTS
  • 2019-03. Yield of Colonoscopy in Identification of Newly Diagnosed Desmoid-Type Fibromatosis with Underlying Familial Adenomatous Polyposis in ANNALS OF SURGICAL ONCOLOGY
  • 2019-03. Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2019-03. Use of the Xi robotic platform for total abdominal colectomy: a step forward in minimally invasive colorectal surgery in SURGICAL ENDOSCOPY
  • 2019-03. Value of adding dynamic contrast-enhanced MRI visual assessment to conventional MRI and clinical assessment in the diagnosis of complete tumour response to chemoradiotherapy for rectal cancer in EUROPEAN RADIOLOGY
  • 2019-03. NFIA is a gliogenic switch enabling rapid derivation of functional human astrocytes from pluripotent stem cells in NATURE BIOTECHNOLOGY
  • 2019-03. Plexiform fibrohistiocytic tumor: imaging features and clinical findings in SKELETAL RADIOLOGY
  • 2019-02-27. Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor in ANNALS OF SURGICAL ONCOLOGY
  • 2019-02-25. Innate lymphocytes—lineage, localization and timing of differentiation in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2019-02-23. Leveraging Latent Dirichlet Allocation in processing free-text personal goals among patients undergoing bladder cancer surgery in QUALITY OF LIFE RESEARCH
  • 2019-02-23. Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy in WORLD JOURNAL OF UROLOGY
  • 2019-02-21. Toward automation of germline variant curation in clinical cancer genetics in GENETICS IN MEDICINE
  • 2019-02-19. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast in ANNALS OF SURGICAL ONCOLOGY
  • 2019-02-15. High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases in JOURNAL OF NEURO-ONCOLOGY
  • 2019-02-15. Understanding Skin Screening Practices Among Children at Elevated Risk for Melanoma to Inform Interventions for Melanoma Prevention and Control in JOURNAL OF CANCER EDUCATION
  • 2019-02-13. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia in LEUKEMIA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "221726884"
        }, 
        "description": "SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER Memorial Sloan-Kettering Cancer Center (MSKCC) is a free-standing NCI-designated Comprehensive Cancer Research Center dedicated to research and training, with the mission of changing and setting the standards of treatment, prevention and control of cancer through inpatient and outpatient care. MSKCC's research programs are grouped into three categories: Basic Research (Regulation of Cell Behavior, Developmental and Stem Cell Biology, Genomic Integrity, and Molecular Structure); Bridge Research (Cancer Biology and Experimental Pathology, Experimental Therapeutics, Immunology and Transplantation, and Imaging and Radiation Sciences); and Patient-Oriented Research (Clinical Research and Survivorship, Outcomes and Risk). The programs are designed to optimize the use of a large patient population and an extensive, multi-disciplinary staff of clinical and laboratory-based Investigators and to encourage the application of discoveries in the basic sciences in a way that advances the prevention, detection, diagnosis, and treatment of many forms of cancer. Scientific work in the 10 research programs depends on services provided by 34 core facilities. We are requesting funding from the Cancer Center Support Grant (CCSG) for 21 of these core facilities. During the next five years, MSKCC will continue to enlarge its clinical and research facilities and its research and training programs in key research areas. Support is requested to provide developmental funding for the laboratories of new Investigators recruited in research areas aligned with the Center's strategic vision, to support cross-disciplinary pilot projects in population science research, and to support the core facilities.", 
        "endDate": "2018-12-31T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438793", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2438793"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA008748"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "many forms", 
          "treatment", 
          "cell behavior", 
          "core facilities", 
          "patient-oriented research", 
          "imaging", 
          "Radiation Sciences", 
          "research facilities", 
          "basic science", 
          "use", 
          "regulation", 
          "training", 
          "standard", 
          "survivorship", 
          "training program", 
          "way", 
          "research", 
          "basic research", 
          "key research areas", 
          "cross-disciplinary pilot projects", 
          "cancer biology", 
          "cancer", 
          "Outcomes", 
          "stem cell biology", 
          "genomic integrity", 
          "CCSG", 
          "bridge research", 
          "Experimental Therapeutics", 
          "Comprehensive Cancer Research Center", 
          "molecular structure", 
          "outpatient care", 
          "risk", 
          "support", 
          "transplantation", 
          "Center's strategic vision", 
          "laboratory", 
          "MSKCC's research programs", 
          "developmental funding", 
          "diagnosis", 
          "MSKCC", 
          "immunology", 
          "application", 
          "funding", 
          "larger patient population", 
          "mission", 
          "detection", 
          "program", 
          "services", 
          "discovery", 
          "free-standing NCI", 
          "prevention", 
          "population science research", 
          "inpatients", 
          "years", 
          "clinical research", 
          "control", 
          "scientific work", 
          "research program", 
          "new investigators", 
          "multi-disciplinary staff", 
          "research area", 
          "Developmental", 
          "experimental pathology", 
          "investigators", 
          "categories"
        ], 
        "name": "Cancer Center Support Grant", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.51462.34", 
              "name": "SLOAN-KETTERING INST CAN RESEARCH", 
              "type": "Organization"
            }, 
            "familyName": "THOMPSON", 
            "givenName": "CRAIG B", 
            "id": "sg:person.010620654227.65", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.010620654227.65", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438793"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz", 
        "startDate": "1977-01-01T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9406236"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438793'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438793'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438793'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438793'


     

    This table displays all metadata directly associated to this object as RDF triples.

    109 TRIPLES      19 PREDICATES      87 URIs      79 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438793 schema:about anzsrc-for:2211
    2 schema:amount N03b44b554a5b4a73838e34221e220401
    3 schema:description SUPPORT FOR NATIONAL PRIMATE RESEARCH CENTER Memorial Sloan-Kettering Cancer Center (MSKCC) is a free-standing NCI-designated Comprehensive Cancer Research Center dedicated to research and training, with the mission of changing and setting the standards of treatment, prevention and control of cancer through inpatient and outpatient care. MSKCC's research programs are grouped into three categories: Basic Research (Regulation of Cell Behavior, Developmental and Stem Cell Biology, Genomic Integrity, and Molecular Structure); Bridge Research (Cancer Biology and Experimental Pathology, Experimental Therapeutics, Immunology and Transplantation, and Imaging and Radiation Sciences); and Patient-Oriented Research (Clinical Research and Survivorship, Outcomes and Risk). The programs are designed to optimize the use of a large patient population and an extensive, multi-disciplinary staff of clinical and laboratory-based Investigators and to encourage the application of discoveries in the basic sciences in a way that advances the prevention, detection, diagnosis, and treatment of many forms of cancer. Scientific work in the 10 research programs depends on services provided by 34 core facilities. We are requesting funding from the Cancer Center Support Grant (CCSG) for 21 of these core facilities. During the next five years, MSKCC will continue to enlarge its clinical and research facilities and its research and training programs in key research areas. Support is requested to provide developmental funding for the laboratories of new Investigators recruited in research areas aligned with the Center's strategic vision, to support cross-disciplinary pilot projects in population science research, and to support the core facilities.
    4 schema:endDate 2018-12-31T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    6 schema:identifier N78b07b2a65fa41f89100d560fa39bbbf
    7 Nf580c95003934e03992b4290179475b3
    8 schema:inLanguage en
    9 schema:keywords CCSG
    10 Center's strategic vision
    11 Comprehensive Cancer Research Center
    12 Developmental
    13 Experimental Therapeutics
    14 MSKCC
    15 MSKCC's research programs
    16 Outcomes
    17 Radiation Sciences
    18 application
    19 basic research
    20 basic science
    21 bridge research
    22 cancer
    23 cancer biology
    24 categories
    25 cell behavior
    26 clinical research
    27 control
    28 core facilities
    29 cross-disciplinary pilot projects
    30 detection
    31 developmental funding
    32 diagnosis
    33 discovery
    34 experimental pathology
    35 free-standing NCI
    36 funding
    37 genomic integrity
    38 imaging
    39 immunology
    40 inpatients
    41 investigators
    42 key research areas
    43 laboratory
    44 larger patient population
    45 many forms
    46 mission
    47 molecular structure
    48 multi-disciplinary staff
    49 new investigators
    50 outpatient care
    51 patient-oriented research
    52 population science research
    53 prevention
    54 program
    55 regulation
    56 research
    57 research area
    58 research facilities
    59 research program
    60 risk
    61 scientific work
    62 services
    63 standard
    64 stem cell biology
    65 support
    66 survivorship
    67 training
    68 training program
    69 transplantation
    70 treatment
    71 use
    72 way
    73 years
    74 schema:name Cancer Center Support Grant
    75 schema:recipient N3c217c273bfb45cdb0e7c70c1bca7688
    76 sg:person.010620654227.65
    77 https://www.grid.ac/institutes/grid.51462.34
    78 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438793
    79 schema:sdDatePublished 2019-03-07T12:11
    80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    81 schema:sdPublisher N6948a63d5188460b9e2d2c2161a64e8c
    82 schema:startDate 1977-01-01T00:00:00Z
    83 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9406236
    84 sgo:license sg:explorer/license/
    85 sgo:sdDataset grants
    86 rdf:type schema:MonetaryGrant
    87 N03b44b554a5b4a73838e34221e220401 schema:currency USD
    88 schema:value 221726884
    89 rdf:type schema:MonetaryAmount
    90 N3c217c273bfb45cdb0e7c70c1bca7688 schema:member sg:person.010620654227.65
    91 schema:roleName PI
    92 rdf:type schema:Role
    93 N6948a63d5188460b9e2d2c2161a64e8c schema:name Springer Nature - SN SciGraph project
    94 rdf:type schema:Organization
    95 N78b07b2a65fa41f89100d560fa39bbbf schema:name nih_id
    96 schema:value P30CA008748
    97 rdf:type schema:PropertyValue
    98 Nf580c95003934e03992b4290179475b3 schema:name dimensions_id
    99 schema:value 2438793
    100 rdf:type schema:PropertyValue
    101 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
    102 rdf:type schema:DefinedTerm
    103 sg:person.010620654227.65 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
    104 schema:familyName THOMPSON
    105 schema:givenName CRAIG B
    106 rdf:type schema:Person
    107 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    108 https://www.grid.ac/institutes/grid.51462.34 schema:name SLOAN-KETTERING INST CAN RESEARCH
    109 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...